fashion -WSS

fashion

author：fashion 2025-08-12 09:11:18 - browse：9517

Closeup of a human brain affected by Alzheimer's disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. — A brain affected by Alzheimer's disease, at the Museum of Neuroanatomy at the University at Buffalo. David Duprey/AP

Investigators on Wednesday released the first detailed case report about a patient who died after receiving lecanemab, providing a new glimpse into safety concerns surrounding the closely watched experimental Alzheimer’s drug.

An unpublished version of the report was previously written about by Science in November, one of three deaths from the lecanemab trials revealed by Science and STAT. But the published version, in the New England Journal of Medicine, will allow doctors to evaluate the case as they consider whether and how to use a treatment that could be approved by the FDA as soon as this week.

This “will have greater impact on clinicians because it is peer-reviewed and published in the New England Journal,” said Lon Schneider, an Alzheimer’s expert at University of Southern California, who was not affiliated with the work.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Statins may not be needed by millions of people, study suggests

WSS

STAT Virtual Event: ASCO Recap, Live!

Head of FDA's diagnostics center, who led through Covid, retires

High breast density mammograms need follow

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Health care court cases: Humana, Sutter, Novant

hotspot

fashion

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Health care court cases: Humana, Sutter, Novant

Jerome Adams on the need for new antivirals for Covid

Statins may not be needed by millions of people, study suggests

Virginia high school admissions case could be legal follow

To bolster infectious disease surveillance, genomics powerhouses team up

Alkermes shareholders re

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Continuity nursing helped my family in our darkest PICU moments

Deposition: Sackler embraced plan to conceal OxyContin’s strength

hotspot

Medicare drug price lawsuits could be good politics for Biden

Medicare bonuses could stop drug shortages under Senate plan

Future doctors need a strong humanities education

'Essentially witchcraft:' A former naturopath takes on the field

TikTok, Instagram influencers need more rules for drug ads

There's an unseen cost to disruptive road

Wikipedia

knowledge

explore

knowledge